Suchen
BridgeBio Oncology Therapeutics Ord Shs
BBOTZur Watchlist hinzufügen
3.990USD
-0.170-4.09%
Handelsschluss 09-24 16:00（ET）
319.64MMarktkapitalisierung
19.79KGV TTM
Über Unternehmen
BridgeBio Oncology Therapeutics Ord Shs Profil
Börsenkürzel- -
Name des Unternehmens- -
IPO-datum- -
CEO- -
Anzahl der mitarbeiter- -
Wertpapierart- -
Geschäftsjahresende- -
Addresse- -
Stadt- -
Börse- -
Land- -
Postleitzahl- -
Telefon- -
Website- -
Börsenkürzel- -
IPO-datum- -
CEO- -
Führungskräfte von BridgeBio Oncology Therapeutics Ord Shs
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Idan Elmelech
Mr. Idan Elmelech
Chief Operating Officer, Principal Financial Officer
Chief Operating Officer, Principal Financial Officer
14.49K
-2.37%
Mr. Idan Elmelech
Mr. Idan Elmelech
Chief Operating Officer, Principal Financial Officer
Chief Operating Officer, Principal Financial Officer
14.49K
-2.37%
Mr. Marc Cobo
Mr. Marc Cobo
Vice President - Finance, Controller, Principal Accounting Officer
Vice President - Finance, Controller, Principal Accounting Officer
14.14K
+62.48%
Mr. Marc Cobo
Mr. Marc Cobo
Vice President - Finance, Controller, Principal Accounting Officer
Vice President - Finance, Controller, Principal Accounting Officer
14.14K
+62.48%
,
,
--
--
Mr. Pedro J. Beltran, Ph.D.
Mr. Pedro J. Beltran, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Ben (Ben) Yong, M.D.
Mr. Ben (Ben) Yong, M.D.
Chief Medical and Development Officer
Chief Medical and Development Officer
--
--
Ms. Angela Peters
Ms. Angela Peters
Senior Vice President - People
Senior Vice President - People
--
--
Mr. Wang Bin, Ph.D.
Mr. Wang Bin, Ph.D.
Senior Vice President - Drug Discovery
Senior Vice President - Drug Discovery
--
--
Mr. Daniel Watson, Ph.D.
Mr. Daniel Watson, Ph.D.
Senior Vice President - Chemistry, Manufacturing, and Controls
Senior Vice President - Chemistry, Manufacturing, and Controls
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Idan Elmelech
Mr. Idan Elmelech
Chief Operating Officer, Principal Financial Officer
Chief Operating Officer, Principal Financial Officer
14.49K
-2.37%
Mr. Idan Elmelech
Mr. Idan Elmelech
Chief Operating Officer, Principal Financial Officer
Chief Operating Officer, Principal Financial Officer
14.49K
-2.37%
Mr. Marc Cobo
Mr. Marc Cobo
Vice President - Finance, Controller, Principal Accounting Officer
Vice President - Finance, Controller, Principal Accounting Officer
14.14K
+62.48%
Mr. Marc Cobo
Mr. Marc Cobo
Vice President - Finance, Controller, Principal Accounting Officer
Vice President - Finance, Controller, Principal Accounting Officer
14.14K
+62.48%
,
,
--
--
Mr. Pedro J. Beltran, Ph.D.
Mr. Pedro J. Beltran, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von BridgeBio Oncology Therapeutics Ord Shs?
Die fünf größten Anteilseigner von BridgeBio Oncology Therapeutics Ord Shs sind: Mr. Idan Elmelech